URIC ACID AND HYPERTENSION
Authors/Creators
Description
Background: Serum uric acid (SUA) has got increasing interest as a potential marker and possible contributor to
hypertension. Hyperuricemia frequently coexists with obesity and other cardiometabolic risk factors, while experimental
studies have proposed mechanisms involving endothelial dysfunction, oxidative stress, renal microvascular injury, altered
sodium handling and activation of neurohormonal pathways. The present study evaluated the relationship between SUA and
hypertension in adults and examined associations with blood pressure, obesity, age and sex. Materials and Methods: This
comparative cross-sectional study was conducted over one month, from September 2026 to October 2026, and included 120
adults. Sixty participants were classified as hypertensive cases and 60 as a comparison group. Of the hypertensive
participants, 43 had stage 1 and 17 had stage 2 hypertension. The comparison group included 40 participants with normal
blood pressure and 20 classified as prehypertensive according to the study protocol. Fasting venous blood was collected after
approximately 8–12 hours of fasting. Serum was separated by centrifugation and SUA was measured using an enzymatic
colorimetric uricase-peroxidase (Trinder) method on an automated or semi-automated analyzer. Hyperuricemia was defined
as SUA >6.5 mg/dL. BMI was classified using WHO international BMI categories. Data were analyzed using Epi Info
version 3.5.3, with statistical significance set at p<0.05. Results: Mean age was 50.62±10.04 years among cases and
48.34±12.66 years among comparison participants (p=0.32). Mean SUA was significantly higher among cases than
comparison participants (6.88±1.63 vs 5.35±1.83 mg/dL; p=0.0001). Hyperuricemia was present in 37 (62%) cases and 16
(26%) comparison participants (p=0.0002). Mean SBP was 150.96±9.21 mmHg in cases and 116.08±5.35 mmHg in
comparison participants, while mean DBP was 98.62±10.87 and 75.08±8.20 mmHg, respectively (both p=0.00001). SUA
correlated positively with SBP (r=0.45, p=0.001) and DBP (r=0.44, p=0.001). Participants with SUA >6.5 mg/dL had higher
SBP and DBP than those with SUA ≤6.5 mg/dL. BMI was significantly higher among hyperuricemic participants
(28.28±3.89 vs 23.03±3.49 kg/m²; p=0.00001). Logistic regression showed significant associations of hyperuricemia with
hypertension (OR 4.07, 95% CI 1.59–10.37; p=0.0033) and obesity (OR 7.00, 95% CI 1.65–29.54; p=0.0081). Conclusion:
SUA was substantially higher in hypertensive adults and was positively associated with both systolic and diastolic blood
pressure. Hyperuricemia was also strongly associated with obesity. The findings support SUA as an important correlate of
hypertension in this study population, while prospective studies are required to determine temporal relationships and
causality.